Health

  • June 16, 2026

    Ga. Justices Uphold $42M Verdict In Hospital Death Suit

    The Georgia Supreme Court refused to grant a new trial or lower a $42 million jury verdict in a wrongful death case filed by the fiance and estate of a woman who died in the hospital after giving birth to her daughter by cesarean section.

  • June 16, 2026

    Sanofi Sued Over Qunol CoQ10 'Superior Absorption' Claims

    Sanofi-Aventis US deceives customers into believing its Qunol liquid CoQ10 supplements have "superior absorption" advantages compared to regular CoQ10 products despite scientific testing that shows otherwise and prior legal action that barred it from making similar efficacy claims, alleges a proposed class action filed Monday in New Jersey federal court.

  • June 16, 2026

    Eli Lilly Settles Mounjaro TM Suit Against Seattle Area Clinics

    Eli Lilly has agreed to drop a lawsuit accusing two Washington clinics of ripping off its trademarks for the weight loss drugs Mounjaro and Zepbound, according to a voluntary dismissal motion filed in federal court on Monday, almost two weeks after a judge rejected a resolution proposed by the parties. 

  • June 16, 2026

    WestRock Must Face Class Claims Over Wash. Paper Mill Odor

    A group of Washington and Oregon residents can proceed with a proposed class action accusing paper mill operator WestRock Longview LLC of negligently releasing noxious gases that sickened neighbors and hurt property values, a Washington federal judge ruled Monday.

  • June 16, 2026

    J&J Fails To Undo $65.5M Verdict In Minn. Talc Cancer Case

    A Minnesota state judge on Monday upheld a $65.5 million verdict awarded to a mother of three children who had claimed that Johnson & Johnson's talc products exposed her to asbestos and contributed to her cancer, saying that the jury's decision was supported by the evidence at trial.

  • June 16, 2026

    Cigna Loses Privilege Bid Due To 'Inaccurate, Redundant' Log

    Cigna "improperly asserted privilege" over hundreds of documents that three laboratories sought as part of the discovery process in federal payment litigation in Connecticut, according to a special master appointed by the judge in the consolidated cases.

  • June 16, 2026

    Judge Allows Pfizer, Moderna Defenses In GSK Vax IP Dispute

    A Delaware federal judge on Tuesday permitted Pfizer and Moderna to move ahead with their arguments that GlaxoSmithKline patents the company claims are infringed by the COVID-19 vaccines are unenforceable because of an unreasonable delay in obtaining them.

  • June 16, 2026

    Anti-Abortion Group Renews Bid To Block NJ's Info Demand

    An anti‑abortion pregnancy center urged a federal judge to block New Jersey's attorney general from enforcing a subpoena seeking financial donor information, arguing in a renewed bid for a preliminary injunction that the demand is retaliatory and persists despite a U.S. Supreme Court ruling allowing the group to challenge the investigation.

  • June 16, 2026

    J&J Talc Trial In LA Ends With Deadlocked Jury

    A mistrial was declared Monday by a Los Angeles state judge in a two-month trial over allegations Johnson & Johnson's talc products caused a woman's deadly mesothelioma after the jury deadlocked during deliberations, according to counsel for the plaintiff.

  • June 16, 2026

    Md. Judge Continues Health Case Law Streak With ACA Ruling

    U.S. District Judge Brendan Abell Hurson in Baltimore has been on the bench for less than three years. He's already building an impressive list of healthcare rulings.

  • June 16, 2026

    Pfizer Agrees To Deal To End Depo-Provera MDL

    The plaintiffs in the multidistrict litigation accusing Pfizer of failing to warn consumers of a link between brain tumors and the hormonal contraceptive Depo-Provera have reached an agreement with the pharmaceutical giant, according to an order filed Monday.

  • June 16, 2026

    Academic Group Fights Feds' Bid For Lawsuit Funding Info

    The Association of American Universities told a Massachusetts federal court on Monday it should not be required to open its books to prove it's eligible to recover attorney fees for successfully defeating the U.S. Department of Health and Human Services' caps on indirect research costs last year.

  • June 16, 2026

    Remote Workers Tell 6th Circ. Boot-Up Time Compensable

    Remote call center workers handling inbound patient calls from home have argued before a Sixth Circuit panel that their employer failed to pay them in accordance with the Fair Labor Standards Act for pre-shift computer startup work integral to their jobs.

  • June 16, 2026

    FCC Urged To Revise Test Rule Language

    A trade group representing commercial, scientific and testing laboratories in the U.S. has asked the Federal Communications Commission to narrowly tailor the language of a planned rule that would restrict accreditation for labs that test communications equipment.

  • June 15, 2026

    Med Groups Slam HHS 'Red Herring' Bid To Fast-Track Appeal

    Medical groups who won an order halting the Trump administration's modified childhood vaccination schedule on Monday urged the First Circuit to ignore the U.S. Department of Health and Human Services' "red herring" arguments for an expedited appeal, saying the agency has for months stalled the process.

  • June 15, 2026

    Cognizant, Infosys Can't Shield Execs From Depositions

    Infosys Ltd. and Cognizant TriZetto Software Group Inc. will each have to produce executives to speak on certain topics for depositions in a Texas federal lawsuit over claims that Infosys stole Cognizant's trade secrets to build a competing healthcare software, a special master ruled Monday.

  • June 15, 2026

    DOJ Says NY Court Can't Block Texas Trans Records Probe

    The U.S. Department of Justice urged a New York federal court Monday to deny a request for an order barring the government from seeking transgender minor patients' medical records through a criminal subpoena issued by a Texas grand jury, arguing the court lacks jurisdiction.

  • June 15, 2026

    Attys Want Up To $33M In Long-Running UBH Benefits Fight

    Attorneys for employee benefit plan participants who sued to change how United Behavioral Health processed claims for mental health and substance use disorder treatment asked a California federal court for up to $33 million in fees and expenses for their work on the "groundbreaking" case.

  • June 15, 2026

    Psilocybin Home Access Wouldn't Alter Ore. Law, Court Told

    Allowing homebound patients to consume psilocybin at their residences would not fundamentally change an Oregon voter-approved program, licensed facilitators said Friday, urging a federal court to reject the state health authority's bid to end their disability bias lawsuit.

  • June 15, 2026

    Univ. Of Washington Beats Medical Prof's Bias Suit At Trial

    Jurors have cleared the University of Washington's medical school of liability in an anesthesiology professor's lawsuit alleging that she was unfairly ousted from a director role after complaining of discrimination and harassment, finding that the professor failed to sufficiently prove any of her three claims against the school.

  • June 15, 2026

    FTC Pulls OptumRx Insulin Price Case To Review Final Deal

    The Federal Trade Commission's third and final settlement resolving an in-house case accusing pharmacy benefit managers of inflating insulin prices through rebate schemes is in sight after the agency on Friday pulled from adjudication its allegations against UnitedHealth Group Inc.'s OptumRx to review a deal struck with staffers.

  • June 15, 2026

    Fed. Circ. Declines To Revive Medmix's Dentistry Patent

    The Patent Trial and Appeal Board didn't err when invalidating claims of a Medmix Switzerland AG patent used in the dentistry industry, the Federal Circuit said Monday.

  • June 15, 2026

    Hospital Co. Says Ex-CEO Siphoned $14M For Personal Use

    The former CEO of Healthcare Systems of America is facing a new lawsuit filed by several company entities in Florida state court that claims he used HSA as a personal piggy bank, transferring $14 million from corporate accounts to fund a lavish lifestyle.

  • June 15, 2026

    EEOC Strikes Tentative Deal To End Suit Over Ban On Beards

    The U.S. Equal Employment Opportunity Commission and emergency services provider Global Medical Response told a Colorado federal court they've reached an agreement to resolve the agency's lawsuit alleging that the company's strict no-beard policy violated federal laws.

  • June 15, 2026

    CareFirst Says Intent Standard Was Misread In Stelara Case

    CareFirst is arguing that a Virginia federal judge created a new standard for monopolization claims when he dismissed claims from the company's antitrust suit challenging Johnson & Johnson's protection of its immunosuppressive drug Stelara, arguing he misread a Fourth Circuit decision in ruling that monopolization requires a showing of specific intent.

Expert Analysis

  • To Survive FCA Actions, Small Cos. Must Take Offensive Steps

    Author Photo

    A fumbled response to False Claims Act allegations can doom lower-middle-market businesses, and with FCA enforcement hitting record levels for two years, smaller companies must have offensive strategies ready that focus their limited resources on defeating civil qui tam and federal criminal actions, says Derrelle Janey at Olshan Frome.

  • The Law Firm Merger Diaries: Leadership Strategy After Day 1

    Author Photo

    For law firm leaders, ensuring a newly combined law firm lives up to its promise, both in its first days of operation and well after, includes tough decisions, clear and specific communication, and cheerleading, says Peter Michaud at Ballard Spahr.

  • How US Liability Law Is Becoming The Primary Regulator Of AI

    Author Photo

    Comprehensive federal AI regulation remains fragmented and uncertain — but U.S. courts, applying long-standing doctrines of liability and responsibility, are actively shaping how AI systems are designed, deployed and governed, and companies are aligning their AI practices because courts may hold them accountable if they do not, says Alexander Lima at Wesco International.

  • Record FCA Recoveries Signal Intensified Healthcare Focus

    Author Photo

    In its recently released False Claims Act statistics, the U.S. government's emphasis on record healthcare recoveries and government-initiated healthcare matters last year indicates robust enforcement ahead, though the administration's focus on current policy objectives also extends beyond the healthcare sector, say attorneys at Epstein Becker.

  • Fed. Circ. In Jan.: On The Validity Of Expert Testimony

    Author Photo

    The Federal Circuit's recent decision in Barry v. DePuy, addressing whether expert testimony is admissible even if it does not strictly adhere to the court's claim construction, suggests that exclusion via a Daubert motion is appropriate only when the line to improper testimony is clearly crossed, say attorneys at Knobbe Martens.

  • Methods For Challenging State Civil Investigative Demands

    Author Photo

    Ongoing challenges to enforcement actions underscore the uphill battle businesses face in arguing that a state investigation is prohibited by federal law, but when properly deployed, these arguments present a viable strategy to resist civil investigative demands issued by state attorneys general, say attorneys at Troutman Pepper.

  • Calif.'s Civility Push Shows Why Professionalism Is Vital

    Author Photo

    The California Bar’s campaign against discourteous behavior by attorneys, including a newly required annual civility oath, reflects a growing concern among states that professionalism in law needs shoring up — and recognizes that maintaining composure even when stressed is key to both succeeding professionally and maintaining faith in the legal system, says Lucy Wang at Hinshaw.

  • A Potential Shift In FDA's Approach To Drug Trial Design

    Author Photo

    Recent guidance released by the U.S. Food and Drug Administration clarifying how Bayesian approaches — which combine prior knowledge with new data — may be used in clinical trials reflects the agency's continued interest in innovative trial designs that may accelerate drug approvals, say attorneys at Alston & Bird.

  • Opinion

    SNAP Rule Confusion Risks A Compliance Crisis

    Author Photo

    Recent Supplemental Nutrition Assistance Program food restriction waivers pose a compliance crisis for legal practitioners advising food retailers, amid higher costs and lack of a coherent national standard, says Tyson-Lord Gray at Yeshiva University’s Benjamin N. Cardozo School of Law.

  • Series

    Trivia Competition Makes Me A Better Lawyer

    Author Photo

    Playing trivia taught me to quickly absorb information and recognize when I've learned what I'm expected to know, training me in the crucial skills needed to be a good attorney, and reminding me to be gracious in defeat, says Jonah Knobler at Patterson Belknap.

  • What FDA Guidance Means For Future Of Health Software

    Author Photo

    Two significant final guidance documents released by the U.S. Food and Drug Administration last month reflect a targeted effort to ease innovation friction around specific areas, including singular clinical decision support recommendations and sensor-based wearables, while maintaining established regulatory boundaries, say attorneys at Covington.

  • Opinion

    Federal Preemption In AI And Robotics Is Essential

    Author Photo

    Federal preemption offers a unified front at a decisive moment that is essential for safeguarding America's economic edge in artificial intelligence and robotics against global rivals, harnessing trillions of dollars in potential, securing high-skilled jobs through human augmentation, and defending technological sovereignty, says Steven Weisburd at Shook Hardy.

  • Series

    Law School's Missed Lessons: What Cross-Selling Truly Takes

    Author Photo

    Early-career attorneys may struggle to introduce clients to practitioners in other specialties, but cross-selling becomes easier once they know why it’s vital to their first years of practice, which mistakes to avoid and how to anticipate clients' needs, say attorneys at Moses & Singer.

  • How State FCA Activity May Affect Civil Fraud Enforcement

    Author Photo

    A growing trend of state attorneys general enforcing their False Claims Act analogues independently of the U.S. Department of Justice carries potential repercussions for civil fraud enforcement and qui tam litigation considerations, say Li Yu at Bernstein Litowitz, Ellen London at London & Naor and Gwen Stamper at Vogel Slade.

  • Wage-Based H-1B Rule Amplifies Lottery Risks For Law Firms

    Author Photo

    Under the wage-based H-1B lottery rule taking effect Feb. 27, law firms planning to hire noncitizen law graduates awaiting bar admission should consider their options, as the work performed by such candidates may sit at the intersection of multiple occupational classifications with differing chances of success, says Jun Li at Reid & Wise.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Health archive.